Receives Form 483 with six observation
Divis Laboratories announced that the Company's Unit-2 has been inspected by USFDA from 11 September to 19 September 2017.This inspection was for full cGMP and verification of all Corrective Actions proposed against the previous Inspection observations. Divi's Laboratories announces that all previous observations have been confirmed as completed and resolved.
On completion of this inspection, Divi's Laboratories has received a Form 483 citing six observations which are procedural and the company will be responding to these within the stipulated time.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content